Az Innovative Medicines Initiative 2010-re tervezett tudományos prioritásai, amelyek a későbbiekben megjelenő 3. felhívás témaköreinek alapját képezik.

Summary of Scientific Priorities (Priority-Title-Pillar-Scientific Area)

A.) Assessment of drug induced toxicity in relevant organs – surrogates for early drug failure / Safety-General Safety

B.) Immunological Safety of Biopharmaceuticals / Safety-Immunology

C.) Assessment inflammatory disease / Efficacy- Inflammatory Diseases

D.) Improve the scientific and pre-clinical infrastructure for Tuberculosis medicine / Efficacy – Infectious Diseases

E.) Enhancing translation in neurological disease / Efficacy – CNS

F.) Development of personalized medicine approaches in diabetes / Efficacy – Metabolic Diseases

G.) Fostering a broader understanding of pharmaceutical R&D in the broader public / Education & Training

Bővebb információ: itt